Investors Alert: Sirius XM Holdings Inc. (NASDAQ:SIRI), Galena Biopharma Inc (NASDAQ:GALE), Rite Aid Corporation (NYSE:RAD), Epizyme, Inc. (NASDAQ:EPZM), Sotheby’s (NYSE:BID)

Sirius XM Holdings Inc. (NASDAQ:SIRI) announced that it will offer subscribers a chance to win two tickets to see Pope Francis celebrate mass at Madison Square Garden during his first visit to the United States in September. Sirius XM Holdings Inc. (NASDAQ:SIRI) belongs to Services sector. Its net profit margin is 11.20% and weekly performance is -1.51%. On last trading day company shares ended up $3.91. Sirius XM Holdings Inc. (NASDAQ:SIRI) distance from 50-day simple moving average (SMA50) is 1.96%.

MonoSol Rx announced that its commercial partner, Galena Biopharma Inc (NASDAQ:GALE) has launched Zuplenz® (ondansetron) oral soluble film in the U.S. Monosol Rx, the developer of PharmFilm, is the world leader in the development of oral soluble film for prescription drugs. PharmFilm enables the administration of pharmaceutical products via a film that dissolves in the mouth. Galena Biopharma Inc (NASDAQ:GALE) belongs to Healthcare sector. Its weekly performance is -1.81%. On last trading day company shares ended up $1.63. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -7.64%.

On 06 August, Rite Aid Corporation (NYSE:RAD) on August 03, has announced that Ken Martindale, who is currently president and chief operating officer, has been promoted to the newly created position of CEO of Rite Aid stores, effective immediately. Martindale, 55, will continue to report to John Standley, Rite Aid’s chairman and CEO, and will retain his role as president of Rite Aid Corporation. Rite Aid Corporation (NYSE:RAD) belongs to Services sector. Its net profit margin is 7.80% and weekly performance is 1.79%. On last trading day company shares ended up $9.12. Rite Aid Corporation (NYSE:RAD) distance from 50-day simple moving average (SMA50) is 4.89%.

Epizyme, Inc. (NASDAQ:EPZM) announced today that Robert Bazemore will succeed Robert Gould, Ph.D. as President and Chief Executive Officer of Epizyme, effective September 10, 2015. Robert Bazemore will also join the Epizyme board of directors. Dr. Gould has served on the Epizyme board of directors since 2008 and as CEO for the past five-and-a-half years. Following the transition, he will continue to serve on the board and will serve as a consultant to the company. Epizyme, Inc. (NASDAQ:EPZM) belongs to Healthcare sector. Its weekly performance is -11.33%. On last trading day company shares ended up $19.80. Epizyme, Inc. (NASDAQ:EPZM) distance from 50-day simple moving average (SMA50) is -9.15%.

The Board of Directors of Sotheby’s (NYSE:BID) has declared a quarterly dividend of $0.10 for the third quarter of 2015. The third quarter dividend is payable on 15 September 2015 to shareholders of record as of 1 September 2015. Sotheby’s (NYSE:BID) shares fell -3.43% in last trading session and ended the day at $40.51. BID Gross Margin is 83.50% and its return on assets is 4.40%. Sotheby’s (NYSE:BID) quarterly performance is -6.96%.

Leave a Reply

Your email address will not be published. Required fields are marked *